US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

COYA THERAPEUTICS INC

5.49

+0.19003.58%

Post-market: 5.490.00000.00%17:15 EST

Volume:363.48K

Turnover:1.98M

Market Cap:114.88M

PE:-4.95

High:5.55

Open:5.29

Low:5.27

Close:5.30

52wk High:8.29

52wk Low:4.65

Shares:20.92M

Float Shares:16.83M

Volume Ratio:1.40

T/O Rate:2.16%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-1.1082

EPS(LYR):-0.9765

ROE:-62.18%

ROA:-37.15%

PB:4.21

PE(LYR):-5.62

Loading ...

Overview Company News Filings

BRIEF-Coya Therapeutics Announces Completion Of Patient Enrollment

Coya Therapeutics Completes Enrollment in Investigator-Initiated Study of Low-Dose IL-2 and CTLA4-Ig Combination for Frontotemporal Dementia; Topline Results Expected Q4 2025

Coya Therapeutics Announces Completion of Patient Enrollment of an Investigator-Initiated, Open-Label Study With Low-Dose Il-2 and Ctla4-Ig Combination Treatment in Patients With Mild to Moderate Frontotemporal Dementia

THOMSON REUTERS

Lucid Capital Reaffirms Their Buy Rating on Coya Therapeutics, Inc. (COYA)

Coya Therapeutics, Inc. (COYA) Gets a Buy from Lake Street

Coya Therapeutics Launches ALSTARS Trial to Evaluate COYA 302 for ALS Treatment

Coya Therapeutics, Inc. (COYA) Gets a Buy from Lake Street

Coya Therapeutics Says COYA 303 Shows Promising Anti-Inflammatory Effects in Preclinical Study

MT Newswires Live

Coya Therapeutics' Coya 303 Shows Promising Central Nervous System (CNS) Anti-Inflammatory Effects and Systemic Regulatory T Cell (Treg) Enhancing Effects in a Preclinical Animal Inflammation Model

THOMSON REUTERS

Coya Therapeutics’ COYA 303 shows anti-inflammatory effect in animal study

Coya Therapeutics Is Maintained at Buy by D. Boral Capital

Coya Therapeutics Announces Phase 2 Clinical Trial for COYA 302 in ALS, Affiliated with NEALS Consortium

Coya Therapeutics Inc - on August 29 Received $4.2 Mln Milestone Payment From DR. Reddy's Laboratories Ltd - SEC Filing

THOMSON REUTERS

Coya Therapeutics Inc - to Receive Additional $4.2 Mln Upon First Patient Dosing - SEC Filing

THOMSON REUTERS

Coya Therapeutics Inc. Secures $4.2 Million Milestone Payment from Dr. Reddy's Laboratories Following FDA Acceptance of ALS Clinical Study IND

BUZZ-U.S. STOCKS ON THE MOVE-Artelo Biosciences, Coya, Vital Energy

BUZZ-Coya rises after US FDA nod for ALS therapy mid-stage trial

Shares of Coya Therapeutics Rise 4.7% Premarket After US FDA Accepts Application for Co's ALS Therapy

THOMSON REUTERS

BRIEF-Coya Therapeutics Announces FDA Acceptance Of Investigational New Drug (IND) Application

Coya Therapeutics Inc - FDA Acceptance Enables Phase 2 Study of Coya 302 in Patients With ALS

THOMSON REUTERS

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/COYA/news?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"COYA","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"COYA\",,,,,undefined,":{"symbol":"COYA","market":"US","secType":"STK","nameCN":"COYA THERAPEUTICS INC","latestPrice":5.49,"timestamp":1766178000000,"preClose":5.3,"halted":0,"volume":363477,"hourTrading":{"tag":"盘后","latestPrice":5.49,"preClose":5.49,"latestTime":"17:15 EST","volume":18943,"amount":103993.6115,"timestamp":1766182530344},"delay":0,"floatShares":16831400,"shares":20924500,"eps":-1.108176,"marketStatus":"Market Closed","change":0.19,"latestTime":"12-19 16:00:00 EST","open":5.29,"high":5.55,"low":5.2701,"amount":1976500.8369108,"amplitude":0.052811,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-1.108176,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1766394000000},"marketStatusCode":7,"adr":0,"listingDate":1672290000000,"exchange":"NASDAQ","adjPreClose":5.3,"preHourTrading":{"tag":"盘前","latestPrice":5.39,"preClose":5.3,"latestTime":"09:29 EST","volume":50,"amount":269.5,"timestamp":1766154570095},"postHourTrading":{"tag":"盘后","latestPrice":5.49,"preClose":5.49,"latestTime":"17:15 EST","volume":18943,"amount":103993.6115,"timestamp":1766182530344},"volumeRatio":1.399406167740658,"impliedVol":1.5602,"impliedVolPercentile":0.7547},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"COYA\",,,,,undefined,":{"symbol":"COYA","floatShares":16831400,"roa":"-37.15%","roe":"-62.18%","lyrEps":-0.976498,"volumeRatio":1.399406167740658,"shares":20924500,"dividePrice":0,"high":5.55,"amplitude":0.052811,"preClose":5.3,"low":5.2701,"week52Low":4.65,"pbRate":"4.21","psRate":"28.81","week52High":8.29,"institutionHeld":0,"latestPrice":5.49,"eps":-1.108176,"divideRate":0,"volume":363477,"delay":0,"ttmEps":-1.108176,"open":5.29,"prevYearClose":5.73,"prevWeekClose":6.18,"prevMonthClose":6.51,"prevQuarterClose":5.7,"fiveDayClose":6.18,"twentyDayClose":5.98,"sixtyDayClose":5.31},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/COYA\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-11-12","symbol":"COYA","fiscalQuarterEnding":"2025/09","expectedEps":0.02,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1762923600000,"reportTimeType":"pre","actualEps":-0.1},{"market":"US","date":"2025-08-12","symbol":"COYA","fiscalQuarterEnding":"2025/06","expectedEps":-0.22,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1754971200000,"reportTimeType":"pre","actualEps":-0.36}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"COYA\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"COYA\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.1429,"buy":0.8571,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.8571,"analysts":7,"updateTime":1752037200000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/COYA\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"COYA","date":"2025-12-19","current":-4.954087,"percent":0.511502,"low":-18.170827,"twenty":-10.134497,"median":-6.219749,"eighty":-3.849238,"high":-2.532969,"avg":-7.135773,"sd":3.513061,"marketCap":110899616},"quantilePoints":[{"date":"2022-12-30","current":-4.259584,"twenty":-5.088378,"median":-4.673981,"eighty":-4.199135,"marketCap":45862003},{"date":"2023-01-06","current":-4.198451,"twenty":-4.75686,"median":-4.211892,"eighty":-4.164199,"marketCap":45203803},{"date":"2023-01-13","current":-4.315322,"twenty":-4.421315,"median":-4.259584,"eighty":-4.180381,"marketCap":46462126},{"date":"2023-01-20","current":-4.288262,"twenty":-4.396143,"median":-4.253021,"eighty":-4.180381,"marketCap":46170776},{"date":"2023-01-27","current":-4.181765,"twenty":-4.394298,"median":-4.256303,"eighty":-4.180658,"marketCap":45024142},{"date":"2023-02-03","current":-3.675163,"twenty":-4.351211,"median":-4.234322,"eighty":-4.117451,"marketCap":39569675},{"date":"2023-02-10","current":-3.877804,"twenty":-4.30991,"median":-4.190108,"eighty":-3.84096,"marketCap":41751462},{"date":"2023-02-17","current":-3.850171,"twenty":-4.288262,"median":-4.180381,"eighty":-3.855698,"marketCap":41453946},{"date":"2023-02-24","current":-3.684374,"twenty":-4.288262,"median":-4.153411,"eighty":-3.785695,"marketCap":39668848},{"date":"2023-03-03","current":-4.089655,"twenty":-4.270282,"median":-4.071233,"eighty":-3.770128,"marketCap":44032421},{"date":"2023-03-10","current":-4.23703,"twenty":-4.288262,"median":-4.153411,"eighty":-3.785695,"marketCap":45619175},{"date":"2023-03-17","current":-3.905437,"twenty":-4.29377,"median":-4.180381,"eighty":-3.822538,"marketCap":42048978},{"date":"2023-03-24","current":-3.73964,"twenty":-4.288262,"median":-4.108461,"eighty":-3.73964,"marketCap":40263880},{"date":"2023-03-31","current":-3.218192,"twenty":-4.288262,"median":-4.048207,"eighty":-3.707402,"marketCap":39406041},{"date":"2023-04-06","current":-3.099387,"twenty":-4.273878,"median":-3.979124,"eighty":-3.684448,"marketCap":37951295},{"date":"2023-04-14","current":-3.233436,"twenty":-4.261724,"median":-3.905437,"eighty":-3.63832,"marketCap":39592701},{"date":"2023-04-21","current":-3.534032,"twenty":-4.256278,"median":-3.877804,"eighty":-3.512909,"marketCap":43273430},{"date":"2023-04-28","current":-3.753386,"twenty":-4.253993,"median":-3.850523,"eighty":-3.541339,"marketCap":45959367},{"date":"2023-05-05","current":-4.053981,"twenty":-4.248953,"median":-3.850876,"eighty":-3.590423,"marketCap":49640095},{"date":"2023-05-12","current":-3.858435,"twenty":-4.25448,"median":-3.877804,"eighty":-3.627267,"marketCap":51231762},{"date":"2023-05-19","current":-4.210564,"twenty":-4.257931,"median":-3.905437,"eighty":-3.63832,"marketCap":55907282},{"date":"2023-05-26","current":-3.109224,"twenty":-4.25448,"median":-3.877804,"eighty":-3.560217,"marketCap":41283847},{"date":"2023-06-02","current":-3.431385,"twenty":-4.251665,"median":-3.850876,"eighty":-3.429011,"marketCap":45561450},{"date":"2023-06-09","current":-3.611196,"twenty":-4.244399,"median":-3.84096,"eighty":-3.421013,"marketCap":47948950},{"date":"2023-06-16","current":-3.618688,"twenty":-4.23703,"median":-3.850171,"eighty":-3.424798,"marketCap":48048429},{"date":"2023-06-23","current":-3.566243,"twenty":-4.23703,"median":-3.830566,"eighty":-3.428417,"marketCap":47352075},{"date":"2023-06-30","current":-3.146685,"twenty":-4.23703,"median":-3.818461,"eighty":-3.418016,"marketCap":41781243},{"date":"2023-07-07","current":-3.071764,"twenty":-4.235405,"median":-3.785695,"eighty":-3.362458,"marketCap":40786451},{"date":"2023-07-14","current":-3.041795,"twenty":-4.228928,"median":-3.76675,"eighty":-3.288681,"marketCap":40388534},{"date":"2023-07-21","current":-2.981859,"twenty":-4.224887,"median":-3.746054,"eighty":-3.233436,"marketCap":39592701},{"date":"2023-07-28","current":-3.019319,"twenty":-4.216174,"median":-3.721218,"eighty":-3.218192,"marketCap":40090097},{"date":"2023-08-04","current":-2.876969,"twenty":-4.203296,"median":-3.712007,"eighty":-3.16841,"marketCap":38199993},{"date":"2023-08-11","current":-2.839996,"twenty":-4.188439,"median":-3.693585,"eighty":-3.145639,"marketCap":36807285},{"date":"2023-08-18","current":-2.54832,"twenty":-4.180935,"median":-3.684466,"eighty":-3.105289,"marketCap":33027077},{"date":"2023-08-25","current":-2.709509,"twenty":-4.180381,"median":-3.675163,"eighty":-3.078507,"marketCap":35116139},{"date":"2023-09-01","current":-2.709509,"twenty":-4.180381,"median":-3.63832,"eighty":-3.046291,"marketCap":35116139},{"date":"2023-09-08","current":-3.691995,"twenty":-4.169593,"median":-3.63832,"eighty":-3.044792,"marketCap":47849471},{"date":"2023-09-15","current":-3.546157,"twenty":-4.135431,"median":-3.63832,"eighty":-3.058278,"marketCap":45959367},{"date":"2023-09-21","current":-3.031887,"twenty":-4.1047,"median":-3.619293,"eighty":-3.053783,"marketCap":39294264},{"date":"2023-09-29","current":-3.162374,"twenty":-4.08252,"median":-3.599887,"eighty":-3.071764,"marketCap":40985409},{"date":"2023-10-06","current":-2.594374,"twenty":-4.053747,"median":-3.556227,"eighty":-3.033869,"marketCap":33623952},{"date":"2023-10-13","current":-3.745724,"twenty":-4.05097,"median":-3.54621,"eighty":-3.041795,"marketCap":48545825},{"date":"2023-10-20","current":-3.937616,"twenty":-4.036232,"median":-3.575206,"eighty":-3.043294,"marketCap":51032803},{"date":"2023-10-27","current":-3.645941,"twenty":-4.021495,"median":-3.590557,"eighty":-3.046291,"marketCap":47252596},{"date":"2023-11-03","current":-3.684319,"twenty":-3.985193,"median":-3.599887,"eighty":-3.062774,"marketCap":47749992},{"date":"2023-11-10","current":-3.870934,"twenty":-4.021495,"median":-3.619293,"eighty":-3.071764,"marketCap":47850465},{"date":"2023-11-17","current":-4.057134,"twenty":-4.055242,"median":-3.63832,"eighty":-3.071764,"marketCap":50152180},{"date":"2023-11-24","current":-4.259991,"twenty":-4.064747,"median":-3.645941,"eighty":-3.07577,"marketCap":52659789},{"date":"2023-12-01","current":-4.324905,"twenty":-4.105159,"median":-3.675163,"eighty":-3.082268,"marketCap":53462223},{"date":"2023-12-08","current":-5.631302,"twenty":-4.180381,"median":-3.684374,"eighty":-3.084048,"marketCap":69611225},{"date":"2023-12-15","current":-7.875233,"twenty":-4.205719,"median":-3.689056,"eighty":-3.088687,"marketCap":97349529},{"date":"2023-12-22","current":-7.933482,"twenty":-4.235947,"median":-3.693585,"eighty":-3.093672,"marketCap":98069570},{"date":"2023-12-29","current":-8.842163,"twenty":-4.23703,"median":-3.709704,"eighty":-3.09424,"marketCap":109302208},{"date":"2024-01-05","current":-7.793685,"twenty":-4.253993,"median":-3.715021,"eighty":-3.09424,"marketCap":96341472},{"date":"2024-01-12","current":-7.877698,"twenty":-4.259991,"median":-3.721218,"eighty":-3.097328,"marketCap":97379997},{"date":"2024-01-19","current":-6.724011,"twenty":-4.272114,"median":-3.742682,"eighty":-3.100019,"marketCap":83118725},{"date":"2024-01-26","current":-6.99204,"twenty":-4.300291,"median":-3.753386,"eighty":-3.10427,"marketCap":86431950},{"date":"2024-02-02","current":-7.213454,"twenty":-4.321125,"median":-3.76675,"eighty":-3.109224,"marketCap":89168961},{"date":"2024-02-09","current":-7.935965,"twenty":-4.359055,"median":-3.785695,"eighty":-3.121212,"marketCap":98100263},{"date":"2024-02-16","current":-8.91485,"twenty":-4.404211,"median":-3.812795,"eighty":-3.139255,"marketCap":110200736},{"date":"2024-02-23","current":-10.04523,"twenty":-4.438913,"median":-3.822509,"eighty":-3.140292,"marketCap":124173901},{"date":"2024-03-01","current":-10.476406,"twenty":-5.628056,"median":-3.830566,"eighty":-3.144593,"marketCap":129503871},{"date":"2024-03-08","current":-10.441446,"twenty":-5.900696,"median":-3.837832,"eighty":-3.146685,"marketCap":129071712},{"date":"2024-03-15","current":-11.653399,"twenty":-6.72168,"median":-3.850171,"eighty":-3.146685,"marketCap":144053250},{"date":"2024-03-22","current":-18.042053,"twenty":-6.870845,"median":-3.854655,"eighty":-3.146752,"marketCap":144116957},{"date":"2024-03-28","current":-17.568699,"twenty":-6.99204,"median":-3.858435,"eighty":-3.147022,"marketCap":140335887},{"date":"2024-04-05","current":-16.744948,"twenty":-7.213454,"median":-3.877804,"eighty":-3.154698,"marketCap":133755895},{"date":"2024-04-12","current":-16.708387,"twenty":-7.481482,"median":-3.895399,"eighty":-3.162374,"marketCap":133463852},{"date":"2024-04-19","current":-15.428751,"twenty":-7.933482,"median":-3.905437,"eighty":-3.168361,"marketCap":123242331},{"date":"2024-04-26","current":-15.41047,"twenty":-7.947618,"median":-3.91531,"eighty":-3.168442,"marketCap":123096309},{"date":"2024-05-03","current":-16.050288,"twenty":-8.108228,"median":-3.925864,"eighty":-3.184145,"marketCap":128207070},{"date":"2024-05-10","current":-15.465312,"twenty":-8.157379,"median":-3.945867,"eighty":-3.193076,"marketCap":123534375},{"date":"2024-05-17","current":-12.046492,"twenty":-8.434421,"median":-4.006757,"eighty":-3.19913,"marketCap":124118462},{"date":"2024-05-24","current":-12.027546,"twenty":-8.842163,"median":-4.037702,"eighty":-3.208428,"marketCap":123923260},{"date":"2024-05-31","current":-11.25722,"twenty":-9.523158,"median":-4.053396,"eighty":-3.216239,"marketCap":115986366},{"date":"2024-06-07","current":-10.62197,"twenty":-10.30363,"median":-4.063993,"eighty":-3.218192,"marketCap":109441204},{"date":"2024-06-14","current":-10.636743,"twenty":-10.491151,"median":-4.092919,"eighty":-3.222662,"marketCap":109593417},{"date":"2024-06-21","current":-8.937819,"twenty":-10.481448,"median":-4.104334,"eighty":-3.228445,"marketCap":92088913},{"date":"2024-06-28","current":-8.952592,"twenty":-10.45543,"median":-4.153411,"eighty":-3.232684,"marketCap":92241126},{"date":"2024-07-05","current":-9.602615,"twenty":-10.38956,"median":-4.180381,"eighty":-3.233436,"marketCap":98938502},{"date":"2024-07-12","current":-11.065167,"twenty":-10.462422,"median":-4.190108,"eighty":-3.233436,"marketCap":114007596},{"date":"2024-07-19","current":-10.341278,"twenty":-10.495432,"median":-4.22459,"eighty":-3.240692,"marketCap":106549156},{"date":"2024-07-26","current":-10.858342,"twenty":-10.601287,"median":-4.235676,"eighty":-3.260565,"marketCap":111876613},{"date":"2024-08-02","current":-9.30715,"twenty":-10.601287,"median":-4.23703,"eighty":-3.276491,"marketCap":95894240},{"date":"2024-08-09","current":-8.952592,"twenty":-10.592423,"median":-4.254237,"eighty":-3.285234,"marketCap":92241126},{"date":"2024-08-16","current":-7.71646,"twenty":-10.555339,"median":-4.259991,"eighty":-3.293463,"marketCap":77933096},{"date":"2024-08-23","current":-9.253723,"twenty":-10.495432,"median":-4.262601,"eighty":-3.309966,"marketCap":93458831},{"date":"2024-08-30","current":-9.08794,"twenty":-10.483969,"median":-4.273335,"eighty":-3.333614,"marketCap":91784487},{"date":"2024-09-06","current":-9.057798,"twenty":-10.475972,"median":-4.288262,"eighty":-3.336985,"marketCap":91480061},{"date":"2024-09-13","current":-9.645575,"twenty":-10.467679,"median":-4.305376,"eighty":-3.353467,"marketCap":97416371},{"date":"2024-09-20","current":-9.20851,"twenty":-10.421412,"median":-4.315454,"eighty":-3.374246,"marketCap":93002191},{"date":"2024-09-27","current":-10.188138,"twenty":-10.338323,"median":-4.344348,"eighty":-3.38688,"marketCap":102896042},{"date":"2024-10-04","current":-10.941699,"twenty":-10.338323,"median":-4.360183,"eighty":-3.395897,"marketCap":110506696},{"date":"2024-10-11","current":-10.625204,"twenty":-10.475972,"median":-4.389011,"eighty":-3.411186,"marketCap":107310221},{"date":"2024-10-18","current":-12.056969,"twenty":-10.583908,"median":-4.422276,"eighty":-3.421013,"marketCap":121770464},{"date":"2024-10-25","current":-13.503805,"twenty":-10.624557,"median":-4.764496,"eighty":-3.424798,"marketCap":136382919},{"date":"2024-11-01","current":-10.610132,"twenty":-10.639569,"median":-5.615074,"eighty":-3.429011,"marketCap":107158008},{"date":"2024-11-08","current":-11.259019,"twenty":-10.689241,"median":-5.753016,"eighty":-3.447868,"marketCap":120460649},{"date":"2024-11-15","current":-9.869209,"twenty":-10.838842,"median":-5.907187,"eighty":-3.515296,"marketCap":105591027},{"date":"2024-11-22","current":-10.150294,"twenty":-10.747842,"median":-6.613304,"eighty":-3.52129,"marketCap":108598366},{"date":"2024-11-29","current":-10.181526,"twenty":-10.695836,"median":-6.758971,"eighty":-3.52129,"marketCap":108932515},{"date":"2024-12-06","current":-9.556893,"twenty":-10.66286,"median":-6.852199,"eighty":-3.534032,"marketCap":102249538},{"date":"2024-12-13","current":-9.197728,"twenty":-10.640275,"median":-6.968732,"eighty":-3.546157,"marketCap":98406827},{"date":"2024-12-20","current":-8.182699,"twenty":-10.636743,"median":-6.99204,"eighty":-3.54621,"marketCap":87546990},{"date":"2024-12-27","current":-9.244576,"twenty":-10.634857,"median":-7.16684,"eighty":-3.558448,"marketCap":98908050},{"date":"2025-01-03","current":-9.541277,"twenty":-10.628876,"median":-7.256788,"eighty":-3.564349,"marketCap":102082464},{"date":"2025-01-10","current":-9.010338,"twenty":-10.62391,"median":-7.341641,"eighty":-3.567419,"marketCap":96401934},{"date":"2025-01-17","current":-8.401321,"twenty":-10.617235,"median":-7.51608,"eighty":-3.569184,"marketCap":89886032},{"date":"2025-01-24","current":-9.213344,"twenty":-10.609545,"median":-7.731531,"eighty":-3.571593,"marketCap":98573901},{"date":"2025-01-31","current":-9.494429,"twenty":-10.604242,"median":-7.875233,"eighty":-3.584959,"marketCap":101581241},{"date":"2025-02-07","current":-10.665617,"twenty":-10.609545,"median":-7.934724,"eighty":-3.602149,"marketCap":114111822},{"date":"2025-02-14","current":-10.61877,"twenty":-10.62133,"median":-7.947618,"eighty":-3.612694,"marketCap":113610598},{"date":"2025-02-21","current":-10.009752,"twenty":-10.61877,"median":-7.957599,"eighty":-3.618688,"marketCap":107094696},{"date":"2025-02-28","current":-11.056013,"twenty":-10.61877,"median":-8.042226,"eighty":-3.619898,"marketCap":118288682},{"date":"2025-03-07","current":-10.743696,"twenty":-10.62197,"median":-8.108228,"eighty":-3.622913,"marketCap":114947194},{"date":"2025-03-14","current":-10.134679,"twenty":-10.61877,"median":-8.140788,"eighty":-3.63832,"marketCap":108431292},{"date":"2025-03-21","current":-7.507868,"twenty":-10.61877,"median":-8.131528,"eighty":-3.63832,"marketCap":111722986},{"date":"2025-03-28","current":-7.372996,"twenty":-10.610132,"median":-8.0597,"eighty":-3.645941,"marketCap":109715986},{"date":"2025-04-04","current":-6.125431,"twenty":-10.607197,"median":-8.00338,"eighty":-3.648656,"marketCap":91151239},{"date":"2025-04-11","current":-5.81073,"twenty":-10.603154,"median":-7.947618,"eighty":-3.675163,"marketCap":86468239},{"date":"2025-04-17","current":-5.911884,"twenty":-10.594569,"median":-7.935965,"eighty":-3.675163,"marketCap":87973489},{"date":"2025-04-25","current":-6.945902,"twenty":-10.592423,"median":-7.877698,"eighty":-3.682488,"marketCap":103360487},{"date":"2025-05-02","current":-7.159449,"twenty":-10.558363,"median":-7.770143,"eighty":-3.684363,"marketCap":106538237},{"date":"2025-05-09","current":-6.799791,"twenty":-10.517537,"median":-7.71646,"eighty":-3.684448,"marketCap":101186237},{"date":"2025-05-16","current":-5.787895,"twenty":-10.501662,"median":-7.494675,"eighty":-3.685787,"marketCap":99179238},{"date":"2025-05-23","current":-5.573167,"twenty":-10.491151,"median":-7.462911,"eighty":-3.690819,"marketCap":95499738},{"date":"2025-05-30","current":-5.204226,"twenty":-10.481448,"median":-7.372996,"eighty":-3.692949,"marketCap":89177689},{"date":"2025-06-06","current":-5.631729,"twenty":-10.475105,"median":-7.356137,"eighty":-3.693585,"marketCap":96503238},{"date":"2025-06-13","current":-5.241315,"twenty":-10.467261,"median":-7.341641,"eighty":-3.701875,"marketCap":89813239},{"date":"2025-06-20","current":-5.37796,"twenty":-10.461335,"median":-7.3168,"eighty":-3.709244,"marketCap":92154738},{"date":"2025-06-27","current":-5.758614,"twenty":-10.45223,"median":-7.265955,"eighty":-3.713213,"marketCap":98677488},{"date":"2025-07-03","current":-5.817176,"twenty":-10.430063,"median":-7.253076,"eighty":-3.716195,"marketCap":99680988},{"date":"2025-07-11","current":-6.17343,"twenty":-10.378286,"median":-7.213454,"eighty":-3.720955,"marketCap":105785612},{"date":"2025-07-18","current":-5.817176,"twenty":-10.3533,"median":-7.163144,"eighty":-3.721218,"marketCap":99680988},{"date":"2025-07-25","current":-6.558964,"twenty":-10.350896,"median":-7.092013,"eighty":-3.724902,"marketCap":112391986},{"date":"2025-08-01","current":-5.807416,"twenty":-10.338323,"median":-6.99204,"eighty":-3.740857,"marketCap":99513738},{"date":"2025-08-08","current":-5.953821,"twenty":-10.32596,"median":-6.97962,"eighty":-3.74579,"marketCap":102022487},{"date":"2025-08-15","current":-4.674882,"twenty":-10.323437,"median":-6.940283,"eighty":-3.74752,"marketCap":95082085},{"date":"2025-08-22","current":-5.41908,"twenty":-10.320001,"median":-6.875506,"eighty":-3.754924,"marketCap":110218283},{"date":"2025-08-29","current":-5.517759,"twenty":-10.309706,"median":-6.854093,"eighty":-3.761854,"marketCap":112225293},{"date":"2025-09-05","current":-5.246393,"twenty":-10.301605,"median":-6.808515,"eighty":-3.76497,"marketCap":106706016},{"date":"2025-09-12","current":-5.106599,"twenty":-10.301173,"median":-6.724011,"eighty":-3.76853,"marketCap":103862753},{"date":"2025-09-19","current":-4.720109,"twenty":-10.296958,"median":-6.63442,"eighty":-3.770128,"marketCap":96001964},{"date":"2025-09-26","current":-4.366512,"twenty":-10.282185,"median":-6.51425,"eighty":-3.785695,"marketCap":88810180},{"date":"2025-10-03","current":-4.827011,"twenty":-10.275221,"median":-6.439507,"eighty":-3.802131,"marketCap":98176225},{"date":"2025-10-10","current":-5.155938,"twenty":-10.212758,"median":-6.246632,"eighty":-3.807129,"marketCap":104866257},{"date":"2025-10-17","current":-5.180608,"twenty":-10.197142,"median":-6.190468,"eighty":-3.818461,"marketCap":105368010},{"date":"2025-10-24","current":-5.739785,"twenty":-10.188138,"median":-6.125431,"eighty":-3.822481,"marketCap":116741065},{"date":"2025-10-31","current":-5.03259,"twenty":-10.181526,"median":-6.064471,"eighty":-3.822538,"marketCap":102357495},{"date":"2025-11-07","current":-4.736556,"twenty":-10.181526,"median":-6.012384,"eighty":-3.830156,"marketCap":96336466},{"date":"2025-11-14","current":-4.901019,"twenty":-10.157996,"median":-5.968462,"eighty":-3.830566,"marketCap":99681482},{"date":"2025-11-21","current":-6.788148,"twenty":-10.150294,"median":-6.012384,"eighty":-3.831749,"marketCap":125128246},{"date":"2025-11-28","current":-7.389773,"twenty":-10.150294,"median":-6.057995,"eighty":-3.836615,"marketCap":136218208},{"date":"2025-12-05","current":-6.810851,"twenty":-10.140824,"median":-6.125431,"eighty":-3.837832,"marketCap":125546736},{"date":"2025-12-12","current":-7.094636,"twenty":-10.135435,"median":-6.18807,"eighty":-3.843973,"marketCap":130777850},{"date":"2025-12-19","current":-6.016252,"twenty":-10.134497,"median":-6.219749,"eighty":-3.849238,"marketCap":110899616}],"updateTime":1766362352672},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"COYA\",pageSize:20,pageCount:2,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2571335933","title":"BRIEF-Coya Therapeutics Announces Completion Of Patient Enrollment","url":"https://stock-news.laohu8.com/highlight/detail?id=2571335933","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2571335933?lang=en_us&edition=fundamental","pubTime":"2025-09-29 20:37","pubTimestamp":1759149478,"startTime":"0","endTime":"0","summary":"BRIEF-Coya Therapeutics Announces Completion Of Patient EnrollmentSept 29 (Reuters) - Coya Therapeutics Inc COYA.O:COYA THERAPEUTICS ANNOUNCES COMPLETION OF PATIENT ENROLLMENT OF AN INVESTIGATOR-INITI","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250929:nTUA4JC71F:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["COYA","BK4139"],"gpt_icon":0},{"id":"2571338221","title":"Coya Therapeutics Completes Enrollment in Investigator-Initiated Study of Low-Dose IL-2 and CTLA4-Ig Combination for Frontotemporal Dementia; Topline Results Expected Q4 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2571338221","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2571338221?lang=en_us&edition=fundamental","pubTime":"2025-09-29 20:04","pubTimestamp":1759147440,"startTime":"0","endTime":"0","summary":"Coya Therapeutics Completes Enrollment in Investigator-Initiated Study of Low-Dose IL-2 and CTLA4-Ig Combination for Frontotemporal Dementia; Topline Results Expected Q4 2025. Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Coya Therapeutics Inc. published the original content used to generate this news brief via PR Newswire  on September 29, 2025, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250929:nNDL8mhxDw:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","COYA"],"gpt_icon":0},{"id":"2571493338","title":"Coya Therapeutics Announces Completion of Patient Enrollment of an Investigator-Initiated, Open-Label Study With Low-Dose Il-2 and Ctla4-Ig Combination Treatment in Patients With Mild to Moderate Frontotemporal Dementia","url":"https://stock-news.laohu8.com/highlight/detail?id=2571493338","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2571493338?lang=en_us&edition=fundamental","pubTime":"2025-09-29 20:01","pubTimestamp":1759147290,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250929:nTUA4JC71F:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","COYA"],"gpt_icon":0},{"id":"2569730866","title":"Lucid Capital Reaffirms Their Buy Rating on Coya Therapeutics, Inc. (COYA)","url":"https://stock-news.laohu8.com/highlight/detail?id=2569730866","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2569730866?lang=en_us&edition=fundamental","pubTime":"2025-09-23 03:55","pubTimestamp":1758570932,"startTime":"0","endTime":"0","summary":"In a report released today, Elemer Piros from Lucid Capital reiterated a Buy rating on Coya Therapeutics, Inc., with a price target of $20.00. The ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/lucid-capital-reaffirms-their-buy-rating-on-coya-therapeutics-inc-coya-blurbs?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/lucid-capital-reaffirms-their-buy-rating-on-coya-therapeutics-inc-coya-blurbs?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LCID","COYA"],"gpt_icon":0},{"id":"2569787549","title":"Coya Therapeutics, Inc. (COYA) Gets a Buy from Lake Street","url":"https://stock-news.laohu8.com/highlight/detail?id=2569787549","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2569787549?lang=en_us&edition=fundamental","pubTime":"2025-09-22 20:57","pubTimestamp":1758545830,"startTime":"0","endTime":"0","summary":"Lake Street analyst Chad Messer maintained a Buy rating on Coya Therapeutics, Inc. today and set a price target of $16.00. The company’s shares clo...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/coya-therapeutics-inc-coya-gets-a-buy-from-lake-street-blurbs-2?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/coya-therapeutics-inc-coya-gets-a-buy-from-lake-street-blurbs-2?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","COYA"],"gpt_icon":0},{"id":"2569784854","title":"Coya Therapeutics Launches ALSTARS Trial to Evaluate COYA 302 for ALS Treatment","url":"https://stock-news.laohu8.com/highlight/detail?id=2569784854","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2569784854?lang=en_us&edition=fundamental","pubTime":"2025-09-22 20:02","pubTimestamp":1758542541,"startTime":"0","endTime":"0","summary":"Coya Therapeutics Inc. has announced the launch of the ALSTARS Trial, a Phase 2 clinical study aimed at evaluating the efficacy and safety of COYA 302 for the treatment of Amyotrophic Lateral Sclerosis . This randomized, multi-center, double-blind, placebo-controlled study will involve 120 participants across approximately 25 centers in the United States and Canada. Eligible participants will be randomized to receive one of two doses of COYA 302 or a placebo over a 24-week period. Those completing this phase will have the opportunity to participate in an additional 24-week extension to further assess the long-term safety and efficacy of COYA 302. During this extension, all participants will receive COYA 302. The study results will be presented in the future, specifically on September 29, 2025, at the NEALS Educational Webinar.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely inform","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250922:nNDL6709PJ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["COYA","BK4139"],"gpt_icon":0},{"id":"2568499133","title":"Coya Therapeutics, Inc. (COYA) Gets a Buy from Lake Street","url":"https://stock-news.laohu8.com/highlight/detail?id=2568499133","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2568499133?lang=en_us&edition=fundamental","pubTime":"2025-09-17 20:55","pubTimestamp":1758113741,"startTime":"0","endTime":"0","summary":"Lake Street analyst Chad Messer maintained a Buy rating on Coya Therapeutics, Inc. today and set a price target of $16.00. The company’s shares clo...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/coya-therapeutics-inc-coya-gets-a-buy-from-lake-street-blurbs?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/coya-therapeutics-inc-coya-gets-a-buy-from-lake-street-blurbs?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["COYA","BK4139"],"gpt_icon":0},{"id":"2567008841","title":"Coya Therapeutics Says COYA 303 Shows Promising Anti-Inflammatory Effects in Preclinical Study","url":"https://stock-news.laohu8.com/highlight/detail?id=2567008841","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2567008841?lang=en_us&edition=fundamental","pubTime":"2025-09-16 20:41","pubTimestamp":1758026470,"startTime":"0","endTime":"0","summary":"Coya Therapeutics (COYA) said Tuesday that early preclinical data from the first animal cohort testing its investigational therapy, COYA 303, demonstrated broad systemic and central immunomodulatory e","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["COYA","BK4139"],"gpt_icon":0},{"id":"2567102267","title":"Coya Therapeutics' Coya 303 Shows Promising Central Nervous System (CNS) Anti-Inflammatory Effects and Systemic Regulatory T Cell (Treg) Enhancing Effects in a Preclinical Animal Inflammation Model","url":"https://stock-news.laohu8.com/highlight/detail?id=2567102267","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2567102267?lang=en_us&edition=fundamental","pubTime":"2025-09-16 20:09","pubTimestamp":1758024570,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250916:nFWN3V30GU:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","COYA"],"gpt_icon":0},{"id":"2567107800","title":"Coya Therapeutics’ COYA 303 shows anti-inflammatory effect in animal study","url":"https://stock-news.laohu8.com/highlight/detail?id=2567107800","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2567107800?lang=en_us&edition=fundamental","pubTime":"2025-09-16 20:05","pubTimestamp":1758024325,"startTime":"0","endTime":"0","summary":"Coya Therapeutics (COYA) announced results of a study designed to evaluate the effects of COYA 303, Coya’s investigational biologic combination in ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/coya-therapeutics-coya-303-shows-anti-inflammatory-effect-in-animal-study-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/coya-therapeutics-coya-303-shows-anti-inflammatory-effect-in-animal-study-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["COYA","BK4139"],"gpt_icon":0},{"id":"2564701973","title":"Coya Therapeutics Is Maintained at Buy by D. Boral Capital","url":"https://stock-news.laohu8.com/highlight/detail?id=2564701973","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2564701973?lang=en_us&edition=fundamental","pubTime":"2025-09-04 21:43","pubTimestamp":1756993380,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/COYA/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  September 04, 2025 09:43 ET (13:43 GMT)","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["COYA","LENZ"],"gpt_icon":0},{"id":"2564058371","title":"Coya Therapeutics Announces Phase 2 Clinical Trial for COYA 302 in ALS, Affiliated with NEALS Consortium","url":"https://stock-news.laohu8.com/highlight/detail?id=2564058371","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2564058371?lang=en_us&edition=fundamental","pubTime":"2025-09-04 20:02","pubTimestamp":1756987331,"startTime":"0","endTime":"0","summary":"Coya Therapeutics, Inc., a clinical-stage biotechnology company, has announced that its Phase 2 clinical trial for COYA 302, aimed at evaluating its efficacy and safety in patients with ALS, has been accepted as a NEALS-Affiliated Trial by the NEALS Consortium. The affiliation with NEALS, the world's largest ALS research consortium, is expected to enhance the trial's operational execution and clinical impact through support from NEALS' institutional and community networks. The COYA 302 study, which focuses on enhancing regulatory T cell function, will be presented during the NEALS Educational Webinar on September 29, 2025. The trial's initiation is planned for Q4 2025, following the FDA's acceptance of the COYA 302 IND.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financia","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250904:nNDL3b3qVN:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","COYA"],"gpt_icon":0},{"id":"2564816807","title":"Coya Therapeutics Inc -  on August 29 Received $4.2 Mln Milestone Payment From DR. Reddy's Laboratories Ltd - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2564816807","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2564816807?lang=en_us&edition=fundamental","pubTime":"2025-09-02 20:34","pubTimestamp":1756816447,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250902:nFWN3UP0PL:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","COYA"],"gpt_icon":0},{"id":"2564807894","title":"Coya Therapeutics Inc - to Receive Additional $4.2 Mln Upon First Patient Dosing - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2564807894","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2564807894?lang=en_us&edition=fundamental","pubTime":"2025-09-02 20:34","pubTimestamp":1756816447,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250902:nFWN3UP0PL:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["COYA","BK4139"],"gpt_icon":0},{"id":"2564887807","title":"Coya Therapeutics Inc. Secures $4.2 Million Milestone Payment from Dr. Reddy's Laboratories Following FDA Acceptance of ALS Clinical Study IND","url":"https://stock-news.laohu8.com/highlight/detail?id=2564887807","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2564887807?lang=en_us&edition=fundamental","pubTime":"2025-09-02 20:32","pubTimestamp":1756816324,"startTime":"0","endTime":"0","summary":"Coya Therapeutics Inc. Secures $4.2 Million Milestone Payment from Dr. Reddy's Laboratories Following FDA Acceptance of ALS Clinical Study IND. Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Coya Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on September 02, 2025, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250902:nNDL88Cd5:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","COYA"],"gpt_icon":0},{"id":"2562646221","title":"BUZZ-U.S. STOCKS ON THE MOVE-Artelo Biosciences, Coya, Vital Energy","url":"https://stock-news.laohu8.com/highlight/detail?id=2562646221","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2562646221?lang=en_us&edition=fundamental","pubTime":"2025-08-26 01:43","pubTimestamp":1756143835,"startTime":"0","endTime":"0","summary":"BUZZ-U.S. STOCKS ON THE MOVE-Artelo Biosciences, Coya, Vital EnergyEikon search string for individual stock moves: STXBZThe Day Ahead newsletter: https://refini.tv/3LI4BU7The Morning News Call newslet","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250825:nL6N3UH0B2:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HK0000306701.USD","LU2360032135.SGD","FANG","LU2125154935.USD","RH","TTC","W","HK0000306685.HKD","LU0321505868.SGD","VG","LU0633140727.USD","BK4501","ARTL","LU0359202008.SGD","LU0348825331.USD","COYA","LOW","LU1251922891.USD","SCPH","KDP","IE00BJTD4V19.USD","WSM","LU0081259029.USD","IE00B0JY6N72.USD","DVN","VTLE","AXGN","LU0348788117.USD","BK4553","AEHR","LU0594300419.USD","OABI","LU0328353924.USD","LU0633140560.USD","FN","BK4558","LU0823413660.USD","LU0251131958.USD","LU0327786744.USD","VRNT","NSSC","LAZ","LU1235295612.USD","AEO","LU1046422090.SGD","LU1808992512.USD"],"gpt_icon":1},{"id":"2562530244","title":"BUZZ-Coya rises after US FDA nod for ALS therapy mid-stage trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2562530244","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2562530244?lang=en_us&edition=fundamental","pubTime":"2025-08-25 20:46","pubTimestamp":1756126013,"startTime":"0","endTime":"0","summary":"BUZZ-Coya rises after US FDA nod for ALS therapy mid-stage trial** Shares of Coya Therapeutics COYA.O rise 7.9% to $7.40 premarket** U.S. FDA gives its go-ahead to the drugmaker to study its drug, COYA 302, as a potential treatment of amyotrophic lateral sclerosis  in a mid-stage study** The acceptance of the Investigational New Drug application by the FDA triggers a $4.2 million milestone payment to Coya from Indian drugmaker Dr Reddy's Laboratories REDY.NS ** ALS, also known as Lou Gehrig's disease, is a rare neurological disease that affects the motor neurons in the brain and spinal cord, leading to muscle weakness, paralysis, and eventually, death** Up to last close, stock up 19.7% YTD   ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250825:nL4N3UH0SG:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["COYA","BK4139"],"gpt_icon":0},{"id":"2562241404","title":"Shares of Coya Therapeutics Rise 4.7% Premarket After US FDA Accepts Application for Co's ALS Therapy","url":"https://stock-news.laohu8.com/highlight/detail?id=2562241404","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2562241404?lang=en_us&edition=fundamental","pubTime":"2025-08-25 20:33","pubTimestamp":1756125184,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250825:nFWN3UG056:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["COYA","BK4139"],"gpt_icon":0},{"id":"2562324196","title":"BRIEF-Coya Therapeutics Announces FDA Acceptance Of Investigational New Drug (IND) Application","url":"https://stock-news.laohu8.com/highlight/detail?id=2562324196","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2562324196?lang=en_us&edition=fundamental","pubTime":"2025-08-25 20:23","pubTimestamp":1756124626,"startTime":"0","endTime":"0","summary":"BRIEF-Coya Therapeutics Announces FDA Acceptance Of Investigational New Drug (IND) Application Aug 25 (Reuters) - Coya Therapeutics Inc COYA.O:COYA THERAPEUTICS ANNOUNCES FDA ACCEPTANCE OF INVESTIGATI","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250825:nTUA1LHMBH:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","COYA"],"gpt_icon":0},{"id":"2562249904","title":"Coya Therapeutics Inc - FDA Acceptance Enables Phase 2 Study of Coya 302 in Patients With ALS","url":"https://stock-news.laohu8.com/highlight/detail?id=2562249904","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2562249904?lang=en_us&edition=fundamental","pubTime":"2025-08-25 20:00","pubTimestamp":1756123208,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250825:nTUA1LHMBH:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["COYA","BK4139"],"gpt_icon":0}],"pageSize":20,"totalPage":3,"pageCount":2,"totalSize":55,"code":"91000000","status":"200"}]}}